| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5759565 | MYLAN IRELAND LTD | Galenic compositions comprising calcitonin and their use |
Mar, 2015
(9 years ago) | |
| US5733569 | MYLAN IRELAND LTD | Galenic compositions comprising calcitonin and their use |
Mar, 2015
(9 years ago) | |
Miacalcin is owned by Mylan Ireland Ltd.
Miacalcin contains Calcitonin Salmon.
Miacalcin has a total of 2 drug patents out of which 2 drug patents have expired.
Expired drug patents of Miacalcin are:
- US5759565
- US5733569
Miacalcin was authorised for market use on 17 August, 1995.
Miacalcin is available in spray, metered;nasal dosage forms.
Miacalcin can be used as nasal administration.
The generics of Miacalcin are possible to be released after 31 March, 2015.
Drugs and Companies using CALCITONIN SALMON ingredient
Market Authorisation Date: 17 August, 1995
Treatment: Nasal administration
Dosage: SPRAY, METERED;NASAL
How can I launch a generic of MIACALCIN before it's drug patent expiration?
More Information on Dosage
MIACALCIN family patents
